Biotechnology Companies By Operating Margin

Operating Margin
Operating MarginEfficiencyMarket RiskExp Return
1SER Serina Therapeutics
396.36
(0.04)
 3.57 
(0.16)
2INBX Inhibrx
181.33
(0.01)
 3.46 
(0.02)
3RNAC Cartesian Therapeutics
25.23
(0.09)
 3.34 
(0.31)
4PTGX Protagonist Therapeutics
0.74
 0.09 
 6.46 
 0.59 
5HALO Halozyme Therapeutics
0.59
 0.36 
 1.44 
 0.51 
6SPRY Silverback Therapeutics
0.55
 0.08 
 4.68 
 0.38 
7AMGN Amgen Inc
0.52
 0.18 
 1.53 
 0.28 
8GNFT Genfit
0.51
(0.03)
 3.34 
(0.09)
9UTHR United Therapeutics
0.49
(0.09)
 2.31 
(0.21)
10XOMAP XOMA Corp
0.47
 0.04 
 0.54 
 0.02 
11XOMAO XOMA Corporation
0.47
 0.06 
 0.27 
 0.02 
12CTMX CytomX Therapeutics
0.46
(0.19)
 4.71 
(0.89)
13KRYS Krystal Biotech
0.45
 0.13 
 2.67 
 0.34 
14VRTX Vertex Pharmaceuticals
0.45
 0.25 
 1.50 
 0.37 
15CPRX Catalyst Pharmaceuticals
0.44
 0.10 
 3.32 
 0.32 
16PLX Protalix Biotherapeutics
0.4
 0.18 
 3.51 
 0.65 
17ALKS Alkermes Plc
0.38
 0.12 
 1.94 
 0.23 
18IRWD Ironwood Pharmaceuticals
0.37
(0.25)
 6.40 
(1.60)
19ABBV AbbVie Inc
0.37
 0.16 
 1.40 
 0.22 
20GMAB Genmab AS
0.35
(0.03)
 2.79 
(0.09)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations. A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.